Skip to main content

Find Clinical Trials

Home
Conditions
Monoclonal Gammopathy of Uncertain Significance

Clinical trial condition

Monoclonal Gammopathy of Uncertain Significance

Explore clinical trials studying Monoclonal Gammopathy of Uncertain Significance. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Uncertain Significance trial results

Not Yet Recruiting

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

NCT06987708

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy

NCT05939037

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University Medical Center Utrecht Utrecht, Netherlands

View Trial Details